Latest Risedronic acid Stories
DUBLIN, March 4, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States District Court for the District of New Jersey has found that United States Patent Nos.
PITTSBURGH, June 11, 2014 /PRNewswire/ -- Mylan Inc.
According to a new report from BCC Research,the global market for women’s health therapeutics is expected to grow to $22.5 billion by 2018, with a five-year compound annual growth rate (CAGR)
ChinaMarketResearchReports.com adds Latest Report on “Research Report on China Osteoporosis Drug Market, 2013-2017” to its store. Dallas, TX (PRWEB) November
A recent prospective, randomized, placebo-controlled clinical trial reports that calcium and vitamin D supplementation improves bone density in a group of male veterans with epilepsy who were treated chronically with antiepileptic drugs (AEDs).
Parker Waichman LLP has filed a lawsuit on behalf of a South Carolina woman who took Fosamax (alendronate) and suffered from a subtrochanteric fracture in her right thighbone.
Parker Waichman LLP has filed a lawsuit alleging that Merck’s Fosamax (alendronate) caused two femur fractures in a Maryland woman.
Parker Waichman LLP is filing a lawsuit on behalf of a woman who took Fosamax (alendronate) and suffered a right femur fracture, allegedly due to Fosamax.
- a slit in a tire to drain away surface water and improve traction.